Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q1 EPS by 8c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q1 EPS of ($0.13), $0.08 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• NeuroSense posts narrower H1 loss, targets Canada drug filing by December
• MARA amends Texas power site purchase agreement, posts $100M deposit